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Treatment recommendations for mild hypertension are con-
troversial, particularly as the potential side effects of  the antihy-
per tensive drugs may be significant (Houston,1989; Swislocki,
1989). The U.S. Joint National Committee on Detection, Eva-
luation and Treatment of High Blood Pressure (1993;1997) re-
commends non-drug therapies as the initial treatment for indivi-
duals with mild hypertension. Although this group was not
overly enthusiastic about relaxa tion therapies because in some
studies no significant differences be tween the experimental
group and the control group were found (Van Montfrans, Kare-
m a k e r,  Wieling & Dunning, 1990) there is strong evidence from
a substantial number of  studies that muscle relaxation training
(Davison, Williams, Nezami, Bice & Dequattro,1991; J o h n s t o n
,1991; Alexander, Schneider & Staggers,1 9 9 6; Boota, Varma &
S i n g h, 1995; González y Amigo, 2000; Amigo, Fernández y
González, 2001) can lower  blood pressure  (BP) by clinically sig-
nificant amounts.
Up to the present time, no experimental studies have been ca-
rried out to determine how medication can affect the relaxation
training in blood pressure lowering, using the ambulatory blood
pressure monitoring (ABPM). In addition, in most studies dealing
with the psychological control of essential hypertension, the major
focus has been on BP as the dependent variable. However, more
attention is currently being devoted to heart rate (HR), as this has
been related to the onset of hypertensive disease ( Obrist, 1981)
and with greater coronary heart-disease mortality (Thaulow &
Erikssen, 1991). 
The purpose of this study is to compare the effects of muscle
relaxation training on BP and HR in medicated and unmedicated




Forty patients, twenty-four females and sixteen males, with es-
sential hypertension participated in the study. All subjects were se-
lected from the Hypertension Unit of Asturias General Hospital,
Oviedo (Spain) and fulfilled the following requirements: (a) diag-
nosis of mild essential hypertension with diastolic blood pressure
between 90 and 104 at the end of baseline sessions; (b) with a mi-
nimum duration of six months; (c) aged between 18 and 60 years;
(d) absence of psychiatric disturbances; (f) no treatment for any
other cardiovascular disease.
Muscle relaxation and continuous ambulatory blood pressure in mild
hypertension
Isaac Amigo, Ángela Fernández, Ana González and Julio Herrera
University of Oviedo
The objective of this study is to compare the effects of muscle relaxation on blood pressure (BP) and
heart rate (HR) in medicated and unmedicated essential hypertensives using as dependent measures the
ambulatory blood pressure monitoring (ABPM). Forty patients were randomly allocated to four diffe-
rent groups: relaxation medicated, relaxation unmedicated, control medicated and control unmedica-
ted. Relaxation groups were superior to the control groups in reducing BP at post-treatment for systo-
lic blood pressure (SBP) and HR and, at follow-up, for SBP and diastolic blood pressure (DBP). Re-
laxation training is of value in significantly reducing BP in medicated and unmedicated hypertensives
and HR in unmedicated.
Relajación muscular y monitorización ambulatoria de la presión arterial en la hipertensión esencial
ligera. El objetivo de este estudio es comparar los efectos del entrenamiento en relajación muscular so-
bre la presión arterial (PA) y la frecuencia cardíaca (FC) en pacientes hipertensos esenciales medica-
dos y no medicados, tomando como variables dependientes la monitorización ambulatoria de la pre-
sión arterial (MAPA). Cuarenta pacientes fueron asignados al azar a cuatro grupos diferentes de trata-
miento: relajación medicado, relajación no medicado, control medicado y control no medicado. Los
grupos de relajación fueron superiores a los grupos control en cuanto a la reducción de la PA sistólica
y la FC a la finalización del tratamiento y, en el periodo de seguimiento, mostraron mayores reduccio-
nes en la PA sistólica y en la PA diastólica. Se concluye que el entrenamiento en relajación parece efec-
tivo para reducir la PA en pacientes hipertensos tanto medicados como no medicados y la FC en pa-






Psicothema ISSN 0214 - 9915 CODEN PSOTEG
2002. Vol. 14, nº 1, pp. 47-52 Copyright © 2002 Psicothema
Apparatus
A DINAMAP 845-XT automatic sphygmomanometer was
used for measurement of blood pressure and heart rate in hospital
by the investigators in the clinic.
A SPACELABS 90202 ambulatory blood pressure monitoring
was used for measurement of blood pressure and heart rate during
24 hours. 
Measures
Fifty-four subjects were mailed invitations to attend a personal
interview designed to introduce a non-pharmacological treatment
for essential hypertension. After the details of the treatment were
explained, those who agreed to participate, underwent the follo-
wing baseline period of evaluation. After a resting period of five
minutes, three separate measurements of blood pressure, with an
interval of two minutes between each, were obtained for each sub-
ject. The mean of the last two measurements was considered as the
score on the dependent variables (systolic and diastolic blood
pressure and heart rate) for the session. The baseline period for all
subjects lasted between 23 and 28 days, depending on the sub-
jects´ availability. During this period, four blood pressure and he-
art rate measurements were obtained for each subject. Those pa-
tients whose diastolic BP was between 90-104 were included in
the study and submitted to the ABPM. Eight patients did not fulfil
this requirement and were excluded from this study. In this way,
no patient with white coat hypertension was included in the rese-
arch, as was confirmed in the results of ABPM. Six patients refu-
se to participate in the study before being allocated at any group. 
Procedure
Each of the 40 subjects was randomly assigned to one of the
four following groups (Table 1): the unmedicated relaxation group
(G1=10), unmedicated control group (G2=10), medicated relaxa-
tion group (G3=10), medicated control group (G4=10). All 40
subjects completed the study. Subjects in the medicated groups
were treated with calcium antagonists and beta blocking agents. In
the medicated relaxation group 7 subjects were taking beta bloc-
king agents and 3 subjects calcium antagonists. In the medicated
control group 5 subjects were taking beta blocking agents and 5
subjects calcium antagonists. The 40 participants signed a consent
form detailing the measurement procedures and informing them
that they would receive one of the two BP control programmes.
The decision as to which drug would be preferable to used was
based on a variety of considerations and characteristics for each
particular patient. Nevertheless, all drugs had the same therapeu-
tic efficacy. Except for the therapist and the participants, all others
involved in the study (doctor and nurses) were blinded with res-
pect to the participants’ treatment group, in order to the medical
decissions would not be affected by the knowlegde of the treat-
ment condition that each one of the patients was receiving. 
Subjects included in the «relaxation groups» were exposed to a
progressive muscular relaxation program of eight sessions, in ad-
dition to homework assignments aimed at providing self-control
over stressful situations encountered in daily life. This involved
eight one-hour weekly treatment sessions during which partici-
pants met individually with the therapist. Homework inter-session
assignments included: daily practice of relaxation, subjective self-
assessment of relaxation practice, and confrontation «in vivo»
with stressful situations (Amigo, Buceta, Bueno & Becoña, 1991).
(Table 2).
The patients in the control group also came to hypertensión unit
1 time a week for 8 weeks. Their BP were taken after 10 minute’s
rest on a couch. They were neither instructed in relaxation nor told
their BP levels.
Statistical Analysis
Analysis of covariance, with pre-treatment BP or HR as the co-
variate, was used to test the treatment group differences in post-
treatment and follow-up blood pressure readings. Analysis of co-
variance was made to test the effects of treatment as this reduces
the bias caused by differences between groups that exist before the
treatments are administered. A Student «t» test was used for the
post hoc comparisons. Analysis of variance was used to test the
treatment group differences in relation to weight, age, SBP, DBP
and HR at referral during the first baseline session. 
Results
Analysis of variance showed that the groups did not differ re-
liably with respect to weight, SBP, DBP and HR as measured at re-
ferral during the first baseline session. The participants’ average
body weight, measured at referral and at post-treatment, did not
change over the study period, and no significant difference was
found between groups. In relation to age, no significant difference
between groups was found. 
AMBULATORY BLOOD PRESSURE (24 hours, table 3)
Systolic blood pressure. Analysis of covariance revealed a tre-
atment group difference on SBP (p<.000), at post-treatment. Sub-
sequent analysis using a student A«t» test revealed significant dif-
ferences between the unmedicated relaxation group and unmedi-
cated control group (p<.052), between the medicated relaxation
group and medicated control group (p<.006) and between the un-
medicated relaxation group and medicated control group (p<.008).
A Student «t» test showed that SBP decreased significantly in the
unmedicated relaxation group (p<.000) and medicated relaxation
group (p<.001). The unmedicated control group increased signifi-
cantly SBP (p<.036). The results were similar at 6 month follow-
up (p<.000). Subsequent analysis revealed significant differences
between the unmedicated relaxation group and unmedicated con-
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Table 1
Group characteristics
Group Sex Age (yr)
Unmedicated Female 4 Mean = 47.10
Relaxation Male  6 SD = 10.10
Unmedicated Female 7 Mean = 42.7
Control Male  3 SD = 13.2
Medicated Female 6 Mean = 46.8
Relaxation Male  4 SD = 11.01
Medicated Female 7 Mean = 54.5
Control Male  3 SD = 8.2
trol group (p<.013), between the medicated relaxation group and
medicated control group (p<.000) and between the unmedicated
relaxation group and medicated control group (p<.002). A Student
«t» test showed that SBP decreased significantly in the medicated
relaxation group (p<.01).
Diastolic blood pressure. Analysis of covariance revealed no
treatment group difference on DBP, at post-treatment. However, at
6 month follow-up revealed a treatment group difference on DBP
(p<.000). Subsequent analysis using a student A«t» test revealed
significant differences between the unmedicated relaxation group
and unmedicated control group (p<.005), between the medicated
relaxation group and medicated control group (p<.014) and bet-
ween the unmedicated relaxation group and medicated control
group (p<.024). A Student «t» test showed that DBP decreased
significantly in the unmedicated relaxation group (p<.011) and in
the medicated relaxation group (p<.004).
Heart rate. Analysis of covariance revealed a treatment group
difference on HR (p<.011), at post-treatment. Subsequent analysis
revealed significant differences between the unmedicated relaxa-
tion group and unmedicated control group (p<.005). A Student «t»
test showed that HR decreased significantly in the unmedicated re-
laxation group (p<.050) and medicated relaxation group (p<.027).
At follow-up, analysis of covariance revealed no treatment group
difference on HR.
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Table 2
Basic intervention procedure for subjects included in the group having the relaxation programme
Sessions work with therapist Homework intersession assignments
1.
– Brief explanation of the nature and goals of the programme – Daily practice of relaxation
– Training in progressive relaxation – Subjective self-assessment of relaxation practice
– Discussion about patients homework assignments – Keeping record of stressful situations
2.
– Brief discussion about homework assignments – Daily practice of relaxation
– Training in progressive relaxation – Subjective self-assessment of relaxation practice
– Setting imaginal scenes of low- intensity of stressful situations – Keeping record and self-rating of stressful situations
– Discussion about patients next hornework
3.
– Brief discussion about homework assignments – Daily practice of relaxation
– Setting imaginal scenes of medium-intensity of stressful situations – Subjective self-assessment of relaxation practice
– Training in progressive relaxation – Specific record and self-rating of stressful situations 
– Discussion about patients next hornework
4. 
– Brief discussion about homework assignments – Daily practice of relaxation
– Training in progressive relaxation – Subjective self-assessment of relaxation practice
– Confrontation in imagination with stressful situations of low and medium intensity, – Confrontation in vivo with stressful scenes of low and medium intensity, using the
using the muscle relaxation muscle relaxation
– Discussion about patients next hornework – Keeping record and self-rating of in vivo confrontation experience
5.
– Brief discussion about homework assignments – Daily practice of relaxation
– Training in progressive relaxation – Subjective self-assessment of relaxation practice
– Confrontation in imagination with stressful situations of higher intensity, using the – Specific record and self-rating of stressful situations
muscle relaxation – C onfrontation in vivo with  stressful scenes of higher inten sity, using the muscle relaxation
6,7,8. 
– Brief discussion about homework assignments – Daily practice of relaxation
– Training in progressive relaxation – Subjective self-assessment of relaxation practice
– Confrontation in imagination with scenes of high stress – Self-monitoring and confrontation in vivo with stressful situations
– Discussion with the patient about the behavioural skills learned during the training
and the way of applying these skills in the future
Table 3
Ambulatory Blood Pressure Monitoring and Heart Rate Data (24 hours)
Group Pre-treatment Post-treatment Follow-up 
mean (SD) mean (SD) mean (SD)     
(1) Unmedicated
Relaxation
SBP 141.5 (14.84) 127.7 (12.45) 128.2 (11.52)
DBP 90.1 (10.52) 80.6 (7.38) 78.8 (7.9)   
HR 81.3 (12.95) 73.1 (5.74) 72.2 (6.76)  
(2) Unmedicated
Control
SBP 134.3 (8.12) 138.2 (10.14) 141.2 (9.45)  
DBP 86.5 (8.93) 87.5 (9.29) 89.5 (6.84)  
HR 81.7 (8.12) 82.3 (7.12) 83.4 (6.6)   
(3) Medicated
Relaxation
SBP 134.2 (12.73) 127.9 (11.23) 125 (9.78)   
DBP 85 (10.31) 79 (7.62) 78 (7.62)
HR 76.8 (10.17) 71.9 (8.74) 71.5 (9.24)
(4) Medicated
Control
SBP 140.1 (16.99) 144.1 (12.03) 146.8 (11.02)
DBP 85.9 (10.18) 86.7 (11.15) 89.5 (11.08)
HR 71.6 (13.28) 74.4 (14.16) 77.1 (14.62)
AMBULATORY BLOOD PRESSURE (nocturnal from 24
AM to 6 AM, table 4)
Systolic blood pre s s u re. Analysis of covariance revealed a treat-
ment group difference on SBP (p<.000), at post-treatment. Subse-
quent analysis revealed significant differences between the unme-
dicated relaxation group and unmedicated control group (p<.025),
between the medicated relaxation group and medicated control
group (p<.015) and between the unmedicated relaxation group and
medicated control group (p<.011). A Student «t» test showed that
SBP decreased significantly in the unmedicated relaxation group
(p<.000) and medicated relaxation group (p<.017). The unmedica-
ted control group increased SBP significantly (p<.030). The results
were similar at 6 month follow-up (p<000). Subsequent analysis re-
vealed significant differences between the unmedicated relaxation
group and unmedicated control group (p<.009), between the medi-
cated relaxation group and medicated control group (p<.007) and
between the unmedicated relaxation group and medicated control
group (p<.015). A Student «t» test showed that SBP decreased sig-
nificantly in the medicated relaxation group (p<.002) and unmedi-
cated relaxation group (p<.017). The unmedicated control group
increased significantly the SBP (p<.035). 
Diastolic blood pressure. Analysis of covariance revealed a tre-
atment group difference on DBP, at post-treatment ( p<.000). Sub-
sequent analysis revealed significant differences between the un-
medicated relaxation group and unmedicated control group
(p<.010). A Student «t» test showed that DBP decreased signifi-
cantly in the unmedicated relaxation group (p<.004) and in the
medicated relaxation group (p<.012).
Heart rate. Analysis of covariance revealed a treatment group
difference on HR (p<.001), at post-treatment. Subsequent analysis
revealed significant differences between the unmedicated relaxa-
tion group and unmedicated control group (p<.002). A Student «t»
test showed that HR decreased significantly in the unmedicated re-
laxation group (p<.047) and medicated relaxation group (p<.026).
At follow-up, analysis of covariance revealed no treatment group
difference on HR.
Medication
Subjects who had medication prescribed before treatment con-
tinued on it at post-treatment. At 6 month follow-up, however,
four unmedicated control group subjects were started on medica-
tion and five medicated control group subjects increased their me-
dication consumption by 50%. In contrast, six medicated relaxa-
tion group subjects reduced their medication consumption by
50%, and only one increased the medication.
Clinical relevance of the results
According to established criteria (Helgeland, 1980) significant
clinical reductions were considerated when systolic BP reduction
is more than 10 mm Hg, diastolic BP drops more than 5 mm Hg
and HR decreases by more than 5 beats by minute. 
Seven subjects in the unmedicated relaxation group and 6 in the
medicated relaxation group demonstrated marked clinical reduc-
tions in their SBP and/or DBP at post-treatment, while only 2 sub-
jects in the unmedicated control group, and 1 in the medicated
control group, did so. At the 6-month follow-up, 7 subjects in the
unmedicated relaxation group and 8 in the medicated relaxation
group demonstrated marked clinical reductions in their systolic
and/or diastolic blood pressure at post-treatment, while only 2 sub-
jects in the unmedicated control group, and nobody in the medica-
ted control group, did so.
Concerning HR, 4 subjects in the unmedicated relaxation group
and 5 in the medicated relaxation group demonstrated marked cli-
nical reductions, while only 1 subject in the unmedicated control
group, and one in the medicated control group, did so. At the 6-
month follow-up, 5 subjects in the unmedicated relaxation group
and 5 in the medicated relaxation group demonstrated marked cli-
nical reductions in their HR at post-treatment, while only 2 sub-
jects in the unmedicated control group, and nobody in the medica-
ted control group, did so.
Discussion
The results of this study clearly demonstrate that relaxation
training is of value in significantly reducing systolic blood pressu-
re in medicated and unmedicated essential hypertension and heart
rate in unmedicated hypertensives. These results of the relaxation
groups were clearly superior to those observed in the control
groups at post-treatment. At 6 month follow-up, these reductions
persisted for systolic blood pressure and were significant for dias-
tolic blood pressure, but not with respect to heart rate. In this study
subjects were instructed to continue practicing relaxation techni-
ques after finishing the treatment.
These data are in agreement with other studies employing simi-
lar programs and relaxation training (Patel, Marmot, Te r r y, Carrut-
hers, Hunt & Patel, 1985; Irvine, Johnston, Jenner & Marie, 1986;
Amigo, Gonzalez & Herrera, 1997) and which similarly showed
significant reductions in SBP and/or DBP. H o w e v e r, the findings
are not in agreement with other studies (Van Montfrans, Karema-
k e r, Wieling & Dunning, 1990) in which has been used the ambu-
latory blood pressure monitoring. This can be explained because in
our research the mean blood pressure levels of the subjects at the
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Table 4
Ambulatory Blood Pressure Monitoring and Heart Rate Data
(From 24 AM to 6 AM)
Group Pre-treatment Post-treatment Follow-up 
mean (SD) mean (SD) mean (SD)     
(1) Unmedicated
Relaxation
SBP 134.9 (9.2) 122.1 (8.2) 122.6 (9.6)
DBP 82.5 (7.2) 75.7(9.8) 75.1 (8.1)
HR 68 (9.2) 61.1 (7.2) 61.4(10.5)
(2) Unmedicated
Control
SBP 128.8 (7.5) 134.2 (8.7) 137.5 (7.2)
DBP 82.5 (3.8) 84.9 (6.4) 85.7(6.3)
HR 77.3 (11.8) 79.4 (11.2) 80.4(8.5)
(3) Medicated
Relaxation
SBP 127.9 (8.2) 122.8 (10.1) 120.2 (10)
DBP 80.16.3) 74.7(8.0) 72.5 (8.9)
HR 71.6 (7.7) 65.5 (9.8) 65.1 (10.8)
(4) Medicated
Control
SBP 137.5 (7.5) 139.7 (8.7) 142.07.2)
DBP 81.9 (3.8) 84 (6.4) 85.7 (6.3)
HR 69.4 (11.8) 70 (11.2) 70 (8.5)
begining of the treatment was higher. Furthermore, the results of
BP and HR changes during the nocturnal period, between the 24
hours and 6 a.m. confirm the efficiency of the relaxation training.
The reduction of the cardiovascular activity during the night can be
especially healthy in the hypertensive patients that have a high car-
diovascular risk, because the reduction of ABPM and most all its
nocturnal component, is better correlated with cardiovascular prog-
nosis (Yamamoto, Akiguchi, Oiwa, Hayashi & Kimura, 1998;
G u e y ff i e r, Cornu, Bossard, Mercier, Sebaoun & Jullien, 1999; Ma-
llion, Baguet, Siche, Tremel & De Gaudemaris, 1999).
One issue frequently raised in similar research studies, centers
on whether statistically significant results obtained during such
experimental trials, have any clinical relevance with respect to
long-term blood pressure reduction in essential hypertension. This
study confirms the results of previous research (Amigo, González
& Herrera, 1997) in which the reduction of SBP, DBP and HR had
clinical significance for most subjects in the experimental groups. 
With respect to HR, the reduction observed in the unmedicated
relaxation group was greater than that observed in the unmedica-
ted control group at post-treatment. Probably, no differences was
found between medicated groups because of the effect of medica-
tion (beta-blockers) on HR. In any case, this is an important fin-
ding, based on research demonstrating the following: Mortality in-
creases with increased HR at rest (Thaulow & Erikssen, 1991).
Although anti-hypertensive drugs can lower the risk for cerebro-
vascular accidents and renal insufficiency, they are not effective in
significantly reducing the incidence of angina or myocardial in-
farction (Houston, 1989; Helgeland, 1980). This may relate to the
increased association between hypertension and glucose intoleran-
ce and/or insulin resistance, which are known coronary risk factors
that anti-hypertensive medication can trigger (Houston,1989;
Swislocki, 1989). Finally, the hemodynamic models of hyperten-
sion demonstrate that this disorder follows an evolutionary deve-
lopment in which the initial changes result from an increase in car-
diac output, which can be related to increased HR (Obrist, 1980).
In this regard, others have observed that high resting HR was as-
sociated with high blood pressure after 32 years of follow-up (Gi-
llum, Taylor & Anderson, 1981). This study found that partici-
pants with HR below the mean, had lower blood pressures on fo-
llow-up that averaged 10 mm Hg (SBP) and 5 mm Hg (DBP),
compared to those with a HR above this distribution.
Based on these findings, we believe that additional research is
required to further evaluate the efficacy of non-pharmacological
treatment of mild hypertension on HR. From a hypothetical view-
point, lowering this parameter could theoretically reduce the de-
velopment of hypertensive disease and its consequences. 
On the other hand, the results of the experimental groups (me-
dicated and unmedicated) have shown specific changes in HR.
Only the subjects belonging to the unmedicated relaxation group
showed a significant reduction in HR at the end of the treatment.
This can be explain because most of the subjects of the medicated
relaxation group were taking beta-blockers. This drug provokes a
significant decrease in HR, therefore it is possible that those pa-
tients that they were taking this type of medication had a lower HR
and they would not be so reponsive to HR lowering effects of mus-
cle relaxation.
Finally, it is of interest to consider the effects of non-pharma-
cological approaches on the use of medication. The unmedicated
experimental group resulted in a delay in pharmacological treat-
ment, when compared to the unmedicated control group and six
medicated relaxation group subjects reduced the medication con-
sumption in a 50% while only one increased it. In addition to eco-
nomic savings, this implies, prolonging the period of an improved
quality of life, since antihypertensive drugs can have annoying si-
de effects that interfere with this (Nies, 1975; Croog, Levine & Su-
dilovsky, 1988).
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